ABBOTT LABORATORIES·4

Feb 25, 5:31 PM ET

LANE ANDREW H 4

4 · ABBOTT LABORATORIES · Filed Feb 25, 2020

Insider Transaction Report

Form 4
Period: 2020-02-21
LANE ANDREW H
Senior Vice President
Transactions
  • Award

    Option (right to buy)

    2020-02-21+126,435126,435 total
    Exercise: $87.72From: 2021-02-21Exp: 2030-02-20Common shares (126,435 underlying)
Footnotes (1)
  • [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 42,145 on February 21, 2021, 42,145 on February 21, 2022, and 42,145 on February 21, 2023.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -